Risiko multipler vertebraler Frakturen (MVF) im Zusammenhang mit Knochenmineralverlust nach Absetzen / Risiko für neue primäre maligne Erkrankungen (NPM)
Dolutegravir: Neuralrohrdefekte (Neural Tube Defect, NTD) bei Neugeborenen von Frauen, die zur Zeit der Konzeption im Rahmen der Tsepamo-Studie mit Dolutegravir behandelt wurden
Information about the revision work on the ordinances (Therapeutic Products Ordinance Package IV and ordinance revisions connected with the implementation of the Medicrime Convention)
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
